Index by author

01 March 2008; volume 31, issue 3

A

  1. Agustí, A. G. N.

    1. Barceló, B. et al "Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking." European Respiratory Journal 31.3 (2008): 555-562. Web. 16 Jan. 2021.

  2. Antunes, E.

    1. Mussi, R. K. et al "Exercise training reduces pulmonary ischaemia–reperfusion-induced inflammatory responses." European Respiratory Journal 31.3 (2008): 645-649. Web. 16 Jan. 2021.

  3. Anzueto, A.

    1. Mortensen, E. M. et al "Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia." European Respiratory Journal 31.3 (2008): 611-617. Web. 16 Jan. 2021.

  4. Athanassa, Z.

    1. Athanassa, Z., I. I. Siempos, and M. E. Falagas. "Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review." European Respiratory Journal 31.3 (2008): 625-632. Web. 16 Jan. 2021.

  5. Ayres, J. G.

    1. Henderson, J. et al "Household chemicals, persistent wheezing and lung function: effect modification by atopy?." European Respiratory Journal 31.3 (2008): 547-554. Web. 16 Jan. 2021.

B

  1. BaHammam, A.

    1. BaHammam, A.. "Excessive daytime sleepiness in patients with sleep-disordered breathing." European Respiratory Journal 31.3 (2008): 685-686. Web. 16 Jan. 2021.

  2. Baldassarre, S.

    1. Michils, A., S. Baldassarre, and A. Van Muylem. "Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients." European Respiratory Journal 31.3 (2008): 539-546. Web. 16 Jan. 2021.

  3. Baraldo, S.

    1. Baraldo, S., and M. Saetta. "To reg or not to reg: that is the question in COPD." European Respiratory Journal 31.3 (2008): 486-488. Web. 16 Jan. 2021.

  4. Barceló, B.

    1. Barceló, B. et al "Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking." European Respiratory Journal 31.3 (2008): 555-562. Web. 16 Jan. 2021.

  5. Behr, J.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  6. Brancher, S.

    1. Mussi, R. K. et al "Exercise training reduces pulmonary ischaemia–reperfusion-induced inflammatory responses." European Respiratory Journal 31.3 (2008): 645-649. Web. 16 Jan. 2021.

  7. Brekke, P. H.

    1. Brekke, P. H. et al "Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation." European Respiratory Journal 31.3 (2008): 563-570. Web. 16 Jan. 2021.

  8. Brouillard, C.

    1. Brouillard, C. et al "Endurance shuttle walking test: responsiveness to salmeterol in COPD." European Respiratory Journal 31.3 (2008): 579-584. Web. 16 Jan. 2021.

  9. Brown, S.

    1. Thursfield, R., and S. Brown. "Smoking: leading by example?." European Respiratory Journal 31.3 (2008): 689-690. Web. 16 Jan. 2021.

  10. Brusasco, V.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.
    2. Pellegrino, R. et al " From the authors ." European Respiratory Journal 31.3 (2008): 688-689. Web. 16 Jan. 2021.

  11. Buhl, R.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  12. Burgos, F.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

C

  1. Camargo, E. A.

    1. Mussi, R. K. et al "Exercise training reduces pulmonary ischaemia–reperfusion-induced inflammatory responses." European Respiratory Journal 31.3 (2008): 645-649. Web. 16 Jan. 2021.

  2. Camps Serra, M.

    1. Camps Serra, M. et al "Virological diagnosis in community-acquired pneumonia in immunocompromised patients." European Respiratory Journal 31.3 (2008): 618-624. Web. 16 Jan. 2021.

  3. Canapini, C.

    1. Miniati, M. et al "Value of chest radiography in phenotyping chronic obstructive pulmonary disease." European Respiratory Journal 31.3 (2008): 509-515. Web. 16 Jan. 2021.

  4. Capron, F.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  5. Casaburi, R.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

  6. Casanova, C.

    1. Cote, C. G. et al "Validation and comparison of reference equations for the 6-min walk distance test." European Respiratory Journal 31.3 (2008): 571-578. Web. 16 Jan. 2021.

  7. Celli, B. R.

    1. Cote, C. G. et al "Validation and comparison of reference equations for the 6-min walk distance test." European Respiratory Journal 31.3 (2008): 571-578. Web. 16 Jan. 2021.

  8. Cervera, C.

    1. Camps Serra, M. et al "Virological diagnosis in community-acquired pneumonia in immunocompromised patients." European Respiratory Journal 31.3 (2008): 618-624. Web. 16 Jan. 2021.

  9. Chew, A. D.

    1. Chew, A. D. et al "Effects of allergen on airway narrowing dynamics as assessed by lung-slice technique." European Respiratory Journal 31.3 (2008): 532-538. Web. 16 Jan. 2021.

  10. Choe, Y. H.

    1. Lee, K. S. et al "Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway." European Respiratory Journal 31.3 (2008): 523-531. Web. 16 Jan. 2021.

  11. Clement, A.

    1. Clement, A., and E. Eber. "Interstitial lung diseases in infants and children." European Respiratory Journal 31.3 (2008): 658-666. Web. 16 Jan. 2021.

  12. Coates, A.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

  13. Copeland, L. A.

    1. Mortensen, E. M. et al "Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia." European Respiratory Journal 31.3 (2008): 611-617. Web. 16 Jan. 2021.

  14. Cornell, J. E.

    1. Mortensen, E. M. et al "Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia." European Respiratory Journal 31.3 (2008): 611-617. Web. 16 Jan. 2021.

  15. Corvasce, G.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  16. Costabel, U.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  17. Cote, C. G.

    1. Cote, C. G. et al "Validation and comparison of reference equations for the 6-min walk distance test." European Respiratory Journal 31.3 (2008): 571-578. Web. 16 Jan. 2021.

  18. Crapo, R. O.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

D

  1. Davies, C. W. H.

    1. Davies, C. W. H.. " From the authors ." European Respiratory Journal 31.3 (2008): 687. Web. 16 Jan. 2021.

  2. Degens, P.

    1. Degens, P., and R. Merget. "Reference values for spirometry of the European Coal and Steel Community: time for change." European Respiratory Journal 31.3 (2008): 687-688. Web. 16 Jan. 2021.

  3. Delbin, M. A.

    1. Mussi, R. K. et al "Exercise training reduces pulmonary ischaemia–reperfusion-induced inflammatory responses." European Respiratory Journal 31.3 (2008): 645-649. Web. 16 Jan. 2021.

  4. Demedts, M.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  5. De Moraes, C.

    1. Mussi, R. K. et al "Exercise training reduces pulmonary ischaemia–reperfusion-induced inflammatory responses." European Respiratory Journal 31.3 (2008): 645-649. Web. 16 Jan. 2021.

  6. de Oca, M. M.

    1. Cote, C. G. et al "Validation and comparison of reference equations for the 6-min walk distance test." European Respiratory Journal 31.3 (2008): 571-578. Web. 16 Jan. 2021.

  7. de Visser, Y. P.

    1. de Visser, Y. P. et al "Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury." European Respiratory Journal 31.3 (2008): 633-644. Web. 16 Jan. 2021.

  8. Dienemann, H.

    1. Warth, A. et al "Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis." European Respiratory Journal 31.3 (2008): 678-680. Web. 16 Jan. 2021.

  9. Dompeling, E.

    1. Rosias, P. P. R. et al "Global condensation: a “climate change” towards better standardisation of exhaled breath condensate measurements." European Respiratory Journal 31.3 (2008): 684-685. Web. 16 Jan. 2021.

  10. Dony, E.

    1. Dony, E. et al "Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition." European Respiratory Journal 31.3 (2008): 599-610. Web. 16 Jan. 2021.

  11. Dordelly, L. J.

    1. Cote, C. G. et al "Validation and comparison of reference equations for the 6-min walk distance test." European Respiratory Journal 31.3 (2008): 571-578. Web. 16 Jan. 2021.

  12. Dumitrascu, R.

    1. Dony, E. et al "Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition." European Respiratory Journal 31.3 (2008): 599-610. Web. 16 Jan. 2021.

E

  1. Eber, E.

    1. Clement, A., and E. Eber. "Interstitial lung diseases in infants and children." European Respiratory Journal 31.3 (2008): 658-666. Web. 16 Jan. 2021.

  2. Ellis, R.

    1. Chew, A. D. et al "Effects of allergen on airway narrowing dynamics as assessed by lung-slice technique." European Respiratory Journal 31.3 (2008): 532-538. Web. 16 Jan. 2021.

F

  1. Falagas, M. E.

    1. Athanassa, Z., I. I. Siempos, and M. E. Falagas. "Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review." European Respiratory Journal 31.3 (2008): 625-632. Web. 16 Jan. 2021.

  2. Falaschi, F.

    1. Miniati, M. et al "Value of chest radiography in phenotyping chronic obstructive pulmonary disease." European Respiratory Journal 31.3 (2008): 509-515. Web. 16 Jan. 2021.

  3. Farrow, A.

    1. Henderson, J. et al "Household chemicals, persistent wheezing and lung function: effect modification by atopy?." European Respiratory Journal 31.3 (2008): 547-554. Web. 16 Jan. 2021.

  4. Fehrenbach, A.

    1. Fehrenbach, H. et al "Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice." European Respiratory Journal 31.3 (2008): 515-522. Web. 16 Jan. 2021.

  5. Fehrenbach, H.

    1. Fehrenbach, H. et al "Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice." European Respiratory Journal 31.3 (2008): 515-522. Web. 16 Jan. 2021.

  6. Ferreira, T.

    1. Mussi, R. K. et al "Exercise training reduces pulmonary ischaemia–reperfusion-induced inflammatory responses." European Respiratory Journal 31.3 (2008): 645-649. Web. 16 Jan. 2021.

  7. Ferrer, J. M.

    1. Barceló, B. et al "Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking." European Respiratory Journal 31.3 (2008): 555-562. Web. 16 Jan. 2021.

  8. Flockerzi, D.

    1. Dony, E. et al "Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition." European Respiratory Journal 31.3 (2008): 599-610. Web. 16 Jan. 2021.

  9. Flower, C. D. R.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  10. Franklin, P.

    1. Franklin, P.. "Household chemicals: good housekeeping or occupational hazard?." European Respiratory Journal 31.3 (2008): 489-491. Web. 16 Jan. 2021.

  11. Fuster, A.

    1. Barceló, B. et al "Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking." European Respiratory Journal 31.3 (2008): 555-562. Web. 16 Jan. 2021.

G

  1. Geist, R.

    1. Hill, K. et al "Anxiety and depression in end-stage COPD." European Respiratory Journal 31.3 (2008): 667-677. Web. 16 Jan. 2021.

  2. Ghofrani, H. A.

    1. Dony, E. et al "Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition." European Respiratory Journal 31.3 (2008): 599-610. Web. 16 Jan. 2021.

  3. Goldstein, R. S.

    1. Hill, K. et al "Anxiety and depression in end-stage COPD." European Respiratory Journal 31.3 (2008): 667-677. Web. 16 Jan. 2021.

  4. Gosker, H. R.

    1. Remels, A. H. et al "Peroxisome proliferator-activated receptors: a therapeutic target in COPD?." European Respiratory Journal 31.3 (2008): 502-508. Web. 16 Jan. 2021.

  5. Grimminger, F.

    1. Dony, E. et al "Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition." European Respiratory Journal 31.3 (2008): 599-610. Web. 16 Jan. 2021.

  6. Gustafsson, P.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

H

  1. Hankinson, J.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

  2. Henderson, J.

    1. Henderson, J. et al "Household chemicals, persistent wheezing and lung function: effect modification by atopy?." European Respiratory Journal 31.3 (2008): 547-554. Web. 16 Jan. 2021.

  3. Herpel, E.

    1. Warth, A. et al "Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis." European Respiratory Journal 31.3 (2008): 678-680. Web. 16 Jan. 2021.

  4. Herth, F. J. F.

    1. Warth, A. et al "Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis." European Respiratory Journal 31.3 (2008): 678-680. Web. 16 Jan. 2021.

  5. Hibi, S.

    1. Teramoto, S. et al "Variation in the tumour necrosis factor-α gene is not associated with susceptibility to Asian COPD." European Respiratory Journal 31.3 (2008): 682-683. Web. 16 Jan. 2021.

  6. Hill, K.

    1. Hill, K. et al "Anxiety and depression in end-stage COPD." European Respiratory Journal 31.3 (2008): 667-677. Web. 16 Jan. 2021.

  7. Hirota, J. A.

    1. Chew, A. D. et al "Effects of allergen on airway narrowing dynamics as assessed by lung-slice technique." European Respiratory Journal 31.3 (2008): 532-538. Web. 16 Jan. 2021.

  8. Hoffmann, A. L.

    1. Milman, N., and A. L. Hoffmann. "Childhood sarcoidosis: long-term follow-up." European Respiratory Journal 31.3 (2008): 592-598. Web. 16 Jan. 2021.

  9. Hoffmann, H.

    1. Warth, A. et al "Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis." European Respiratory Journal 31.3 (2008): 678-680. Web. 16 Jan. 2021.

  10. Holmedal, S. H.

    1. Brekke, P. H. et al "Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation." European Respiratory Journal 31.3 (2008): 563-570. Web. 16 Jan. 2021.

  11. Hong, S. H.

    1. Lee, K. S. et al "Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway." European Respiratory Journal 31.3 (2008): 523-531. Web. 16 Jan. 2021.

  12. Hong, S. J.

    1. Lee, K. S. et al "Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway." European Respiratory Journal 31.3 (2008): 523-531. Web. 16 Jan. 2021.

I

  1. Inman, M. D.

    1. Chew, A. D. et al "Effects of allergen on airway narrowing dynamics as assessed by lung-slice technique." European Respiratory Journal 31.3 (2008): 532-538. Web. 16 Jan. 2021.

  2. Ishii, M.

    1. Teramoto, S. et al "Variation in the tumour necrosis factor-α gene is not associated with susceptibility to Asian COPD." European Respiratory Journal 31.3 (2008): 682-683. Web. 16 Jan. 2021.

  3. Ishii, T.

    1. Teramoto, S. et al "Variation in the tumour necrosis factor-α gene is not associated with susceptibility to Asian COPD." European Respiratory Journal 31.3 (2008): 682-683. Web. 16 Jan. 2021.

J

  1. Janssen, L. J.

    1. Chew, A. D. et al "Effects of allergen on airway narrowing dynamics as assessed by lung-slice technique." European Respiratory Journal 31.3 (2008): 532-538. Web. 16 Jan. 2021.

  2. Jensen, R.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

  3. Jiménez, D.

    1. Otero, R., and D. Jiménez. "Pulmonary embolism at home." European Respiratory Journal 31.3 (2008): 686-687. Web. 16 Jan. 2021.

  4. Jiménez de Anta, M. T.

    1. Camps Serra, M. et al "Virological diagnosis in community-acquired pneumonia in immunocompromised patients." European Respiratory Journal 31.3 (2008): 618-624. Web. 16 Jan. 2021.

  5. Jöbsis, Q.

    1. Rosias, P. P. R. et al "Global condensation: a “climate change” towards better standardisation of exhaled breath condensate measurements." European Respiratory Journal 31.3 (2008): 684-685. Web. 16 Jan. 2021.

  6. Johnson, D. C.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

  7. Jolley, C.

    1. Luo, Y. M. et al "Neural respiratory drive during apnoeic events in obstructive sleep apnoea." European Respiratory Journal 31.3 (2008): 650-657. Web. 16 Jan. 2021.

K

  1. Kim, J. S.

    1. Lee, K. S. et al "Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway." European Respiratory Journal 31.3 (2008): 523-531. Web. 16 Jan. 2021.

  2. Kim, S. R.

    1. Lee, K. S. et al "Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway." European Respiratory Journal 31.3 (2008): 523-531. Web. 16 Jan. 2021.

L

  1. Lacasse, Y.

    1. Brouillard, C. et al "Endurance shuttle walking test: responsiveness to salmeterol in COPD." European Respiratory Journal 31.3 (2008): 579-584. Web. 16 Jan. 2021.
    2. Hill, K. et al "Anxiety and depression in end-stage COPD." European Respiratory Journal 31.3 (2008): 667-677. Web. 16 Jan. 2021.

  2. Laghmani, E. H.

    1. de Visser, Y. P. et al "Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury." European Respiratory Journal 31.3 (2008): 633-644. Web. 16 Jan. 2021.

  3. Lai, Y-J.

    1. Dony, E. et al "Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition." European Respiratory Journal 31.3 (2008): 599-610. Web. 16 Jan. 2021.

  4. Landucci, E. C. T.

    1. Mussi, R. K. et al "Exercise training reduces pulmonary ischaemia–reperfusion-induced inflammatory responses." European Respiratory Journal 31.3 (2008): 645-649. Web. 16 Jan. 2021.

  5. Langen, R. C.

    1. Remels, A. H. et al "Peroxisome proliferator-activated receptors: a therapeutic target in COPD?." European Respiratory Journal 31.3 (2008): 502-508. Web. 16 Jan. 2021.

  6. Lankhorst, I.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  7. Laurent, F.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  8. Lee, K. S.

    1. Lee, K. S. et al "Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway." European Respiratory Journal 31.3 (2008): 523-531. Web. 16 Jan. 2021.

  9. Lee, K. Y.

    1. Lee, K. S. et al "Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway." European Respiratory Journal 31.3 (2008): 523-531. Web. 16 Jan. 2021.

  10. Lee, Y. C.

    1. Lee, K. S. et al "Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway." European Respiratory Journal 31.3 (2008): 523-531. Web. 16 Jan. 2021.

  11. Lee, Y. R.

    1. Lee, K. S. et al "Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway." European Respiratory Journal 31.3 (2008): 523-531. Web. 16 Jan. 2021.

  12. Levy, P.

    1. Pellegrino, R. et al " From the authors ." European Respiratory Journal 31.3 (2008): 688-689. Web. 16 Jan. 2021.

  13. Lopez, M. V.

    1. Cote, C. G. et al "Validation and comparison of reference equations for the 6-min walk distance test." European Respiratory Journal 31.3 (2008): 571-578. Web. 16 Jan. 2021.

  14. Luo, Y. M.

    1. Luo, Y. M. et al "Neural respiratory drive during apnoeic events in obstructive sleep apnoea." European Respiratory Journal 31.3 (2008): 650-657. Web. 16 Jan. 2021.

M

  1. MacIntyre, N.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

  2. Maltais, F.

    1. Brouillard, C. et al "Endurance shuttle walking test: responsiveness to salmeterol in COPD." European Respiratory Journal 31.3 (2008): 579-584. Web. 16 Jan. 2021.

  3. Marcos, M. A.

    1. Camps Serra, M. et al "Virological diagnosis in community-acquired pneumonia in immunocompromised patients." European Respiratory Journal 31.3 (2008): 618-624. Web. 16 Jan. 2021.

  4. Marín, J. M.

    1. Cote, C. G. et al "Validation and comparison of reference equations for the 6-min walk distance test." European Respiratory Journal 31.3 (2008): 571-578. Web. 16 Jan. 2021.

  5. McKay, R.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

  6. Mehling, T.

    1. Fehrenbach, H. et al "Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice." European Respiratory Journal 31.3 (2008): 515-522. Web. 16 Jan. 2021.

  7. Merget, R.

    1. Degens, P., and R. Merget. "Reference values for spirometry of the European Coal and Steel Community: time for change." European Respiratory Journal 31.3 (2008): 687-688. Web. 16 Jan. 2021.

  8. Michils, A.

    1. Michils, A., S. Baldassarre, and A. Van Muylem. "Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients." European Respiratory Journal 31.3 (2008): 539-546. Web. 16 Jan. 2021.

  9. Michl, V.

    1. Fehrenbach, H. et al "Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice." European Respiratory Journal 31.3 (2008): 515-522. Web. 16 Jan. 2021.

  10. Miller, M. R.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

  11. Milman, N.

    1. Milman, N., and A. L. Hoffmann. "Childhood sarcoidosis: long-term follow-up." European Respiratory Journal 31.3 (2008): 592-598. Web. 16 Jan. 2021.

  12. Milot, J.

    1. Brouillard, C. et al "Endurance shuttle walking test: responsiveness to salmeterol in COPD." European Respiratory Journal 31.3 (2008): 579-584. Web. 16 Jan. 2021.

  13. Min, K. H.

    1. Lee, K. S. et al "Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway." European Respiratory Journal 31.3 (2008): 523-531. Web. 16 Jan. 2021.

  14. Miniati, M.

    1. Miniati, M. et al "Value of chest radiography in phenotyping chronic obstructive pulmonary disease." European Respiratory Journal 31.3 (2008): 509-515. Web. 16 Jan. 2021.

  15. Mirarchi, G.

    1. Miniati, M. et al "Value of chest radiography in phenotyping chronic obstructive pulmonary disease." European Respiratory Journal 31.3 (2008): 509-515. Web. 16 Jan. 2021.

  16. Monti, S.

    1. Miniati, M. et al "Value of chest radiography in phenotyping chronic obstructive pulmonary disease." European Respiratory Journal 31.3 (2008): 509-515. Web. 16 Jan. 2021.

  17. Moreno, A.

    1. Camps Serra, M. et al "Virological diagnosis in community-acquired pneumonia in immunocompromised patients." European Respiratory Journal 31.3 (2008): 618-624. Web. 16 Jan. 2021.

  18. Mortensen, E. M.

    1. Mortensen, E. M. et al "Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia." European Respiratory Journal 31.3 (2008): 611-617. Web. 16 Jan. 2021.

  19. Moxham, J.

    1. Luo, Y. M. et al "Neural respiratory drive during apnoeic events in obstructive sleep apnoea." European Respiratory Journal 31.3 (2008): 650-657. Web. 16 Jan. 2021.

  20. Mussi, R. K.

    1. Mussi, R. K. et al "Exercise training reduces pulmonary ischaemia–reperfusion-induced inflammatory responses." European Respiratory Journal 31.3 (2008): 645-649. Web. 16 Jan. 2021.

N

  1. Navajas, D.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

  2. Nekach, H.

    1. Cote, C. G. et al "Validation and comparison of reference equations for the 6-min walk distance test." European Respiratory Journal 31.3 (2008): 571-578. Web. 16 Jan. 2021.

  3. Nicholson, A. G.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  4. Nieuwland, K.

    1. de Visser, Y. P. et al "Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury." European Respiratory Journal 31.3 (2008): 633-644. Web. 16 Jan. 2021.

  5. Nyengaard, J. R.

    1. Fehrenbach, H. et al "Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice." European Respiratory Journal 31.3 (2008): 515-522. Web. 16 Jan. 2021.

O

  1. Omland, T.

    1. Brekke, P. H. et al "Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation." European Respiratory Journal 31.3 (2008): 563-570. Web. 16 Jan. 2021.

  2. Otero, R.

    1. Otero, R., and D. Jiménez. "Pulmonary embolism at home." European Respiratory Journal 31.3 (2008): 686-687. Web. 16 Jan. 2021.

  3. Ouchi, Y.

    1. Teramoto, S. et al "Variation in the tumour necrosis factor-α gene is not associated with susceptibility to Asian COPD." European Respiratory Journal 31.3 (2008): 682-683. Web. 16 Jan. 2021.

P

  1. Park, S. J.

    1. Lee, K. S. et al "Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway." European Respiratory Journal 31.3 (2008): 523-531. Web. 16 Jan. 2021.

  2. Pedersen, O. F.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

  3. Pellegrino, R.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.
    2. Pellegrino, R. et al " From the authors ." European Respiratory Journal 31.3 (2008): 688-689. Web. 16 Jan. 2021.

  4. Pepin, V.

    1. Brouillard, C. et al "Endurance shuttle walking test: responsiveness to salmeterol in COPD." European Respiratory Journal 31.3 (2008): 579-584. Web. 16 Jan. 2021.

  5. Perelló, R.

    1. Camps Serra, M. et al "Virological diagnosis in community-acquired pneumonia in immunocompromised patients." European Respiratory Journal 31.3 (2008): 618-624. Web. 16 Jan. 2021.

  6. Pinto-Plata, V.

    1. Cote, C. G. et al "Validation and comparison of reference equations for the 6-min walk distance test." European Respiratory Journal 31.3 (2008): 571-578. Web. 16 Jan. 2021.

  7. Polkey, M. I.

    1. Luo, Y. M. et al "Neural respiratory drive during apnoeic events in obstructive sleep apnoea." European Respiratory Journal 31.3 (2008): 650-657. Web. 16 Jan. 2021.

  8. Pons, J.

    1. Barceló, B. et al "Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking." European Respiratory Journal 31.3 (2008): 555-562. Web. 16 Jan. 2021.

  9. Pugh, J. A.

    1. Mortensen, E. M. et al "Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia." European Respiratory Journal 31.3 (2008): 611-617. Web. 16 Jan. 2021.

  10. Pugh, M. J.

    1. Mortensen, E. M. et al "Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia." European Respiratory Journal 31.3 (2008): 611-617. Web. 16 Jan. 2021.

  11. Pullamsetti, S. S.

    1. Dony, E. et al "Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition." European Respiratory Journal 31.3 (2008): 599-610. Web. 16 Jan. 2021.

  12. Pumarola, T.

    1. Camps Serra, M. et al "Virological diagnosis in community-acquired pneumonia in immunocompromised patients." European Respiratory Journal 31.3 (2008): 618-624. Web. 16 Jan. 2021.

R

  1. Rabe, K. F.

    1. Miniati, M. et al "Value of chest radiography in phenotyping chronic obstructive pulmonary disease." European Respiratory Journal 31.3 (2008): 509-515. Web. 16 Jan. 2021.

  2. Rabinovich, R.

    1. Miniati, M. et al "Value of chest radiography in phenotyping chronic obstructive pulmonary disease." European Respiratory Journal 31.3 (2008): 509-515. Web. 16 Jan. 2021.

  3. Remels, A. H.

    1. Remels, A. H. et al "Peroxisome proliferator-activated receptors: a therapeutic target in COPD?." European Respiratory Journal 31.3 (2008): 502-508. Web. 16 Jan. 2021.

  4. Restrepo, M. I.

    1. Mortensen, E. M. et al "Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia." European Respiratory Journal 31.3 (2008): 611-617. Web. 16 Jan. 2021.

  5. Robroeks, C.

    1. Rosias, P. P. R. et al "Global condensation: a “climate change” towards better standardisation of exhaled breath condensate measurements." European Respiratory Journal 31.3 (2008): 684-685. Web. 16 Jan. 2021.

  6. Roca, J.

    1. Miniati, M. et al "Value of chest radiography in phenotyping chronic obstructive pulmonary disease." European Respiratory Journal 31.3 (2008): 509-515. Web. 16 Jan. 2021.

  7. Rosias, P. P. R.

    1. Rosias, P. P. R. et al "Global condensation: a “climate change” towards better standardisation of exhaled breath condensate measurements." European Respiratory Journal 31.3 (2008): 684-685. Web. 16 Jan. 2021.

S

  1. Saetta, M.

    1. Baraldo, S., and M. Saetta. "To reg or not to reg: that is the question in COPD." European Respiratory Journal 31.3 (2008): 486-488. Web. 16 Jan. 2021.

  2. Sardina, M.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  3. Sauleda, J.

    1. Barceló, B. et al "Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking." European Respiratory Journal 31.3 (2008): 555-562. Web. 16 Jan. 2021.

  4. Savai, R.

    1. Dony, E. et al "Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition." European Respiratory Journal 31.3 (2008): 599-610. Web. 16 Jan. 2021.

  5. Schermuly, R. T.

    1. Dony, E. et al "Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition." European Respiratory Journal 31.3 (2008): 599-610. Web. 16 Jan. 2021.

  6. Schirmacher, P.

    1. Warth, A. et al "Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis." European Respiratory Journal 31.3 (2008): 678-680. Web. 16 Jan. 2021.

  7. Schmähl, A.

    1. Warth, A. et al "Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis." European Respiratory Journal 31.3 (2008): 678-680. Web. 16 Jan. 2021.

  8. Schnabel, P. A.

    1. Warth, A. et al "Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis." European Respiratory Journal 31.3 (2008): 678-680. Web. 16 Jan. 2021.

  9. Schols, A. M.

    1. Remels, A. H. et al "Peroxisome proliferator-activated receptors: a therapeutic target in COPD?." European Respiratory Journal 31.3 (2008): 502-508. Web. 16 Jan. 2021.

  10. Schrauwen, P.

    1. Remels, A. H. et al "Peroxisome proliferator-activated receptors: a therapeutic target in COPD?." European Respiratory Journal 31.3 (2008): 502-508. Web. 16 Jan. 2021.

  11. Schudt, C.

    1. Dony, E. et al "Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition." European Respiratory Journal 31.3 (2008): 599-610. Web. 16 Jan. 2021.

  12. Seeger, W.

    1. Fehrenbach, H. et al "Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice." European Respiratory Journal 31.3 (2008): 515-522. Web. 16 Jan. 2021.
    2. Dony, E. et al "Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition." European Respiratory Journal 31.3 (2008): 599-610. Web. 16 Jan. 2021.

  13. Sherriff, A.

    1. Henderson, J. et al "Household chemicals, persistent wheezing and lung function: effect modification by atopy?." European Respiratory Journal 31.3 (2008): 547-554. Web. 16 Jan. 2021.

  14. Siempos, I. I.

    1. Athanassa, Z., I. I. Siempos, and M. E. Falagas. "Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review." European Respiratory Journal 31.3 (2008): 625-632. Web. 16 Jan. 2021.

  15. Smith, P.

    1. Brekke, P. H. et al "Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation." European Respiratory Journal 31.3 (2008): 563-570. Web. 16 Jan. 2021.

  16. Søyseth, V.

    1. Brekke, P. H. et al "Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation." European Respiratory Journal 31.3 (2008): 563-570. Web. 16 Jan. 2021.

  17. Steier, J.

    1. Luo, Y. M. et al "Neural respiratory drive during apnoeic events in obstructive sleep apnoea." European Respiratory Journal 31.3 (2008): 650-657. Web. 16 Jan. 2021.

  18. Stolk, J.

    1. Miniati, M. et al "Value of chest radiography in phenotyping chronic obstructive pulmonary disease." European Respiratory Journal 31.3 (2008): 509-515. Web. 16 Jan. 2021.

T

  1. Tang, J.

    1. Luo, Y. M. et al "Neural respiratory drive during apnoeic events in obstructive sleep apnoea." European Respiratory Journal 31.3 (2008): 650-657. Web. 16 Jan. 2021.

  2. Teramoto, S.

    1. Teramoto, S. et al "Variation in the tumour necrosis factor-α gene is not associated with susceptibility to Asian COPD." European Respiratory Journal 31.3 (2008): 682-683. Web. 16 Jan. 2021.

  3. Thomeer, M.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  4. Thursfield, R.

    1. Thursfield, R., and S. Brown. "Smoking: leading by example?." European Respiratory Journal 31.3 (2008): 689-690. Web. 16 Jan. 2021.

  5. Toro, I. F. C.

    1. Mussi, R. K. et al "Exercise training reduces pulmonary ischaemia–reperfusion-induced inflammatory responses." European Respiratory Journal 31.3 (2008): 645-649. Web. 16 Jan. 2021.

  6. Torres, A.

    1. Camps Serra, M. et al "Virological diagnosis in community-acquired pneumonia in immunocompromised patients." European Respiratory Journal 31.3 (2008): 618-624. Web. 16 Jan. 2021.

V

  1. van de Kant, K.

    1. Rosias, P. P. R. et al "Global condensation: a “climate change” towards better standardisation of exhaled breath condensate measurements." European Respiratory Journal 31.3 (2008): 684-685. Web. 16 Jan. 2021.

  2. van der Grinten, C. P. M.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

  3. Van Muylem, A.

    1. Michils, A., S. Baldassarre, and A. Van Muylem. "Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients." European Respiratory Journal 31.3 (2008): 539-546. Web. 16 Jan. 2021.

  4. van Schayck, C. P.

    1. Rosias, P. P. R. et al "Global condensation: a “climate change” towards better standardisation of exhaled breath condensate measurements." European Respiratory Journal 31.3 (2008): 684-685. Web. 16 Jan. 2021.

  5. van Wijngaarden, S.

    1. de Visser, Y. P. et al "Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury." European Respiratory Journal 31.3 (2008): 633-644. Web. 16 Jan. 2021.

  6. Verbeken, E. K.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  7. Verschakelen, J.

    1. Thomeer, M. et al "Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis." European Respiratory Journal 31.3 (2008): 585-591. Web. 16 Jan. 2021.

  8. Viegi, G.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.
    2. Pellegrino, R. et al " From the authors ." European Respiratory Journal 31.3 (2008): 688-689. Web. 16 Jan. 2021.

  9. Voswinckel, R.

    1. Fehrenbach, H. et al "Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice." European Respiratory Journal 31.3 (2008): 515-522. Web. 16 Jan. 2021.

W

  1. Wagenaar, G. T. M.

    1. de Visser, Y. P. et al "Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury." European Respiratory Journal 31.3 (2008): 633-644. Web. 16 Jan. 2021.

  2. Wagner, P. D.

    1. Wagner, P. D.. "Possible mechanisms underlying the development of cachexia in COPD." European Respiratory Journal 31.3 (2008): 492-501. Web. 16 Jan. 2021.

  3. Walther, F. J.

    1. de Visser, Y. P. et al "Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury." European Respiratory Journal 31.3 (2008): 633-644. Web. 16 Jan. 2021.

  4. Wanger, J.

    1. Pellegrino, R. et al "Definition of COPD: based on evidence or opinion?." European Respiratory Journal 31.3 (2008): 681-682. Web. 16 Jan. 2021.

  5. Warth, A.

    1. Warth, A. et al "Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis." European Respiratory Journal 31.3 (2008): 678-680. Web. 16 Jan. 2021.

  6. Wattie, J.

    1. Chew, A. D. et al "Effects of allergen on airway narrowing dynamics as assessed by lung-slice technique." European Respiratory Journal 31.3 (2008): 532-538. Web. 16 Jan. 2021.

  7. Weibel, E. R.

    1. Weibel, E. R.. "How to make an alveolus." European Respiratory Journal 31.3 (2008): 483-485. Web. 16 Jan. 2021.

  8. Weissmann, N.

    1. Dony, E. et al "Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition." European Respiratory Journal 31.3 (2008): 599-610. Web. 16 Jan. 2021.

  9. Wu, H. D.

    1. Luo, Y. M. et al "Neural respiratory drive during apnoeic events in obstructive sleep apnoea." European Respiratory Journal 31.3 (2008): 650-657. Web. 16 Jan. 2021.

Y

  1. Yamaguchi, Y.

    1. Teramoto, S. et al "Variation in the tumour necrosis factor-α gene is not associated with susceptibility to Asian COPD." European Respiratory Journal 31.3 (2008): 682-683. Web. 16 Jan. 2021.

  2. Yamamoto, H.

    1. Teramoto, S. et al "Variation in the tumour necrosis factor-α gene is not associated with susceptibility to Asian COPD." European Respiratory Journal 31.3 (2008): 682-683. Web. 16 Jan. 2021.

Z

  1. Zanesco, A.

    1. Mussi, R. K. et al "Exercise training reduces pulmonary ischaemia–reperfusion-induced inflammatory responses." European Respiratory Journal 31.3 (2008): 645-649. Web. 16 Jan. 2021.

  2. Zhong, N. S.

    1. Luo, Y. M. et al "Neural respiratory drive during apnoeic events in obstructive sleep apnoea." European Respiratory Journal 31.3 (2008): 650-657. Web. 16 Jan. 2021.

  3. Zimmermann, L. J. I.

    1. Rosias, P. P. R. et al "Global condensation: a “climate change” towards better standardisation of exhaled breath condensate measurements." European Respiratory Journal 31.3 (2008): 684-685. Web. 16 Jan. 2021.
Back to top
European Respiratory Journal: 31 (3)

Search Within This Issue

Jump to

Manage Table of content Alerts